The US Food and Drug Administration (FDA) has granted 510 (k) clearance to Terumo Interventional Systems’ (TIS) OPUSWAVE dual ...
Eli Lilly has reported that its interleukin-13 (IL-13) inhibitor Ebglyss (lebrikizumab-lbkz) showed sustained skin clearance ...
Novartis will pay $72 a share in cash for the biotechnology company, representing a premium of 46% to Avidity’s closing price ...
New data shows the state had an uptick in obesity while other states saw declines, in a year of federal cuts to food ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback